Healthcare / Healthcare PlansNYSE
$379.86
-0.45 (-0.12%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 22% · confianza 25%
FCF escenarios
weak_data · normalized FCF $20.7B · quality 71.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
43/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$345.0B
P/E
28.6x
↑EV/EBITDA
17.3x
↑ROE
12.8%
↑Gross Margin
18.5%
↓Debt/Equity
0.83
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2007–2025 · 18 años de histórico normalizado
Revenue CAGR
+10.4%
FCF CAGR
+6.7%
FCF margin
3.6%
FCF / Net income
1.33x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $447.57B · net income $12.06B · FCF $16.07B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||||
| Revenue | $447.57B | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | $122.49B | $110.62B | $101.86B | $94.16B | $87.14B | $81.19B | $75.43B |
| Net Income | $12.06B | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | $5.63B | $5.53B | $5.14B | $4.63B | $3.82B | $2.98B | $4.65B |
| EBITDA | $23.06B | $23.06B | $28.08B | $36.33B | $31.84B | $27.07B | $25.30B | $22.41B | $19.77B | $17.45B | $14.98B | $12.71B | $11.75B | $11.00B | $10.56B | $9.59B | $8.93B | $7.35B | $6.24B | $8.64B |
| EPS | 13.23 | 13.23 | 15.51 | 23.86 | 21.18 | 18.08 | 16.03 | 14.33 | 12.19 | 10.72 | 7.25 | 6.01 | 5.70 | 5.50 | 5.28 | 4.73 | 4.10 | 3.24 | 2.40 | 3.42 |
| Gross Margin | 18.5% | 18.5% | 22.3% | 24.5% | 24.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 4.2% | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | 7.9% | 8.4% | 8.3% | 8.4% | 7.3% | 6.5% | 10.4% |
| Net Margin | 2.7% | 2.7% | 3.6% | 6.0% | 6.2% | 6.0% | 6.0% | 5.7% | 5.3% | 5.2% | 3.8% | 3.7% | 4.3% | 4.6% | 5.0% | 5.0% | 4.9% | 4.4% | 3.7% | 6.2% |
| Balance Sheet | ||||||||||||||||||||
| Debt/Equity | 0.83 | 0.83 | 0.83 | 0.70 | 0.74 | — | — | — | — | — | — | — | 0.49 | 0.46 | 0.45 | 0.38 | 0.34 | 0.38 | 0.55 | — |
| Current Ratio | 0.80 | 0.80 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||||
| Free Cash Flow | $16.07B | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B | $16.39B | $13.65B | $11.57B | $8.09B | $8.18B | $6.53B | $5.68B | $6.08B | $5.90B | $5.39B | $4.89B | $3.45B | $5.01B |
| Returns | ||||||||||||||||||||
| ROE | 12.8% | 12.8% | 15.5% | 25.2% | 25.9% | — | — | — | — | — | — | — | 17.3% | 17.5% | 17.7% | 18.2% | 17.9% | 16.2% | 14.3% | 23.2% |
| Valuation | ||||||||||||||||||||
| P/E | 28.56 | 28.56 | 33.08 | 22.52 | 23.14 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 17.35 | 17.35 | 18.81 | 14.90 | 15.70 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 3.68 | 3.68 | 5.14 | 5.68 | 5.99 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||||
| Revenue Growth | 11.8% | 11.8% | 7.7% | 14.6% | — | 11.8% | 6.2% | 7.0% | 12.5% | 8.8% | 17.7% | 20.4% | 6.5% | 10.7% | 8.6% | 8.2% | 8.1% | 7.3% | 7.6% | — |
| EPS Growth | -14.7% | -14.7% | -35.0% | 12.7% | — | 12.8% | 11.9% | 17.6% | 13.7% | 47.9% | 20.6% | 5.4% | 3.6% | 4.2% | 11.6% | 15.4% | 26.5% | 35.0% | -29.8% | — |
| Dividend Yield | 2.3% | 2.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
36.6%
EPS terminal req.
$33.71
Spread vs growth
-51.3%
5Y implied EPS CAGR
25.3%
EPS terminal req.
$40.78
Spread vs growth
-40.0%
10Y implied EPS CAGR
17.4%
EPS terminal req.
$65.68
Spread vs growth
-32.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+28.1%
Start / end P/E
19.5x → 28.7x
EPS bridge
15.51 → 13.23
Residual
-7.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.